全文获取类型
收费全文 | 13662篇 |
免费 | 1039篇 |
国内免费 | 673篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 136篇 |
妇产科学 | 266篇 |
基础医学 | 2007篇 |
口腔科学 | 302篇 |
临床医学 | 634篇 |
内科学 | 1642篇 |
皮肤病学 | 255篇 |
神经病学 | 296篇 |
特种医学 | 272篇 |
外国民族医学 | 8篇 |
外科学 | 1038篇 |
综合类 | 2565篇 |
现状与发展 | 2篇 |
预防医学 | 373篇 |
眼科学 | 96篇 |
药学 | 941篇 |
1篇 | |
中国医学 | 248篇 |
肿瘤学 | 4163篇 |
出版年
2024年 | 16篇 |
2023年 | 115篇 |
2022年 | 322篇 |
2021年 | 373篇 |
2020年 | 262篇 |
2019年 | 285篇 |
2018年 | 237篇 |
2017年 | 297篇 |
2016年 | 279篇 |
2015年 | 460篇 |
2014年 | 555篇 |
2013年 | 623篇 |
2012年 | 580篇 |
2011年 | 755篇 |
2010年 | 646篇 |
2009年 | 724篇 |
2008年 | 702篇 |
2007年 | 852篇 |
2006年 | 788篇 |
2005年 | 753篇 |
2004年 | 696篇 |
2003年 | 730篇 |
2002年 | 646篇 |
2001年 | 688篇 |
2000年 | 612篇 |
1999年 | 548篇 |
1998年 | 494篇 |
1997年 | 440篇 |
1996年 | 341篇 |
1995年 | 237篇 |
1994年 | 129篇 |
1993年 | 77篇 |
1992年 | 41篇 |
1991年 | 13篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1974年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的比较骨填充网袋椎体成形术(Vesselplasty)与经皮椎体后凸成形术(percutaneous kyphoplasty,PKP)治疗 Kümmell 病的临床疗效。方法2015 年 1 月—2018 年 12 月收治 63 例 Kümmell 病患者,其中 28 例采用 Vesselplasty 治疗(Vesselplasty 组),35 例采用 PKP 治疗(PKP 组)。两组患者性别、年龄、病程、骨密度 T 值、骨折节段及术前疼痛视觉模拟评分(VAS)、Oswestry 功能障碍指数(ODI)、伤椎前缘高度、后凸 Cobb 角等一般资料比较,差异均无统计学意义(P>0.05),具有可比性。记录两组手术时间、术中透视时间、骨水泥注射量、骨水泥渗漏率、骨水泥弥散面积率和随访期间并发症发生情况,以及术前、术后 1 d、末次随访时 VAS 评分、ODI、伤椎前缘高度、后凸 Cobb 角。 结果两组患者均获随访,随访时间 12~36 个月,平均 24.2 个月。Vesselplasty 组手术时间、术中透视时间、骨水泥注射量、骨水泥弥散面积率均明显小于 PKP 组(P<0.05)。Vesselplasty 组骨水泥渗漏率(7.14%)明显低于 PKP 组(34.29%)(χ2=5.153,P=0.023)。两组患者术后 1 d 及末次随访时 VAS 评分、ODI、伤椎前缘高度、后凸 Cobb 角均较术前显著改善(P<0.05),术后两组间比较差异均无统计学意义(P>0.05)。随访期间两组均未见术椎再塌陷,Vesselplasty 组邻椎骨折发生率(7.14%)与 PKP 组(14.29%)比较,差异无统计学意义(χ2=0.243,P=0.622)。 结论Vesselplasty 和 PKP 治疗 Kümmell 病疗效相似,均能有效缓解患者疼痛症状,改善生活质量,部分恢复伤椎高度,矫正椎体后凸。但前者具有手术时间短、术中透视时间少、骨水泥渗漏少等优势。 相似文献
2.
Joachim Fensterle 《Journal der Deutschen Dermatologischen Gesellschaft》2006,4(3):205-216
Many cellular signaling pathways are involved in the development of cancer. Depending on the tumor entity, the nature as well as the mode of activation can differ. Some signaling pathways frequently show changes as all tumor cells have to fulfill some basic requirements such as independence from growth factors or insensitivity against apoptosis. In this review, the possibilities of a tumor to manipulate signaling pathways to reach these goals are exemplified based on an archetypical melanoma cell. In addition, new therapeutic options based on the knowledge of signaling pathways will be discussed. 相似文献
3.
What is the value of bcl-2 protein detection for histopathologists? 总被引:15,自引:0,他引:15
4.
Objective To test the hypothesis that p53 gene therapy combined with endostatin can enhance tumor response to radiation therapy of RM-1 mouse xenograft prostate cancer and to investigate its mechanism. Methods A mouse prostate cancer model was established. Then mice with xenograft tumor were randomly divided into group A (control), B (radiation), C (radiation and rAdp53), D (radiation and rh-endostatin) and E (radiation and rAdp53 and rh-endostatin). On day 1, rAdp53 was injected intra-tumorously with 1 × 1010 vp per animal to group C and E. From day 1 to 14, rh-endostatin was given 15 mg/kg intraperitoneally daily to group D and E. On day 4 single fraction of 15 Gy was given to tumors in groups B, C, D and E. Normal saline was injected intra-tumorously or intraperitoneaUy accordingly as control. No treatment was done to group A. Tumor volume was measured daily. Samples were collected on Days 5, 10 and 15. Ki67, CD31, p53 and VEGF were detected by means of immunohistochemistry. Results (1) Radiation alone, radiation combined with intra-tumorous injection of Adp53 and/or intraperitoneal injection of rh-endostatin resulted in tumor growth arrest of RM-1 cells in vivo (P = 0.000). Radiation combined with both rAdp53 and rh-endostatin was the most effective treatment (P < 0.05). (2) All the four treatment groups had a decreased expression of mutant type P53 (P = 0.000). The expression of Ki67 in groups B and C were equal (P 0.05) and increasing (P = 0.000), respectively. Group D had a up-down-up curve (P < 0.05), but group E had a up-down one. On day 5 the expresion of VEGF in group E was the lowest (P < 0.05). An increased expression of MVD compared with the control was shown, and MVD in groups C, D and E were always higher than that in the control (P < 0.05). Conclusions The limitation of radiotherapy could be overcome by combination with beth p53 gene therapy and endostatin on the growth of mouse prostate cancer cell. Radiation, rAdp53 and endostatin have their own role but they can be interacted with each other. 相似文献
5.
6.
A. G. Douglas-Jones H. Navabi J. M. Morgan B. Jasani 《Virchows Archiv : an international journal of pathology》1997,430(5):373-379
Immunocytochemically detectable MT and p53 have been found more commonly in comedo DCIS of the breast with high-grade cytology.
The aim of this study is to confirm these findings and to investigate the relationship between MT and p53 in a single large
series of cases of DCIS of the breast. To this end, 127 cases of DCIS were classified histologically according to architecture,
cytonuclear differentiation (grade), presence and extent of intraduct necrosis, and using the Van Nuys system. Sections were
immunostained for p53 and MT (E9) using established techniques, and the extent and intensity of staining were assessed semi-quantitively.
The results confirmed that there was generally more MT and p53 positivity in poorly differentiated (grade 3) DCIS with extensive
necrosis and that MT expression was greater in grade 2 lesions than p53 expression. However, overall there was no statistically
significant correlation between p53 and MT staining. The results indicate that MT and p53 overexpression may arise from independent
mechanisms in early breast neoplasia.
Received: 3 July 1996 / Accepted: 5 November 1996 相似文献
7.
Abstract: We analyzed the expression of CEA, CA19-9, CA125, CA15-3 (DF3), PCNA and p53 immunohistochemically in 14 tissue specimens of mucosal cancers in adenoma, seven tubulovillous adenoma specimens, and 16 tubular adenoma specimens. The rates of positive staining for mucosal cancer in adenoma, tubulovillous adenoma and tubular adenoma specimens, respectively, were: for CEA: 100%, 85.7% and 75%; for CA19-9: 71.4%, 71.4% and 56.2%; for CA125:0%, 0% and 0%;for CA15-3 (DF3): 64.3 %, 0% and 0 %; for PCNA: 100%, 88.9% and 56.2%; and for p53: 35.7%, 0% and 0% . The results suggest that the expressions of CEA, CA19-9, CA15-3 (DF3), PCNA and p53 are related to colorectal tumorigenesis. None of the specimens studied showed staining for CA125, suggesting that CA125 is not involved in the early stages of colorectal carcinogenesis. There was no significant difference in the rates of positive staining for CEA and CA19-9 among mucosal cancer in adenoma, tubular adenoma and tubulovillous adenoma specimens. However, the rates of positive staining for PCNA and p53 were significantly higher in mucosal cancer in adenoma specimens than for tubular adenoma specimens (p<0.05), and the rate of CA15-3 (DF3) positive staining was significantly higher for mucosal cancer in adenoma than for tubulovillous adenoma (p<0.01) and tubular adenoma (p< 0.001) specimens. Therefore, the CA15-3 (DF3) antigen is an immunohistochemical marker for colorectal carcinomas. The present results suggest that CA15-3 (DF3), PCNA and p53 play important roles in the genesis of colorectal adenomas. 相似文献
8.
9.
p53 Protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene 总被引:1,自引:0,他引:1
G. PRUNERI L. PIGNATARO N.S. FRACCHIOLLA S. FERRERO P. CAPACCIO N. CARBONI A. OTTAVIANI A.T. MAIOLO A. NERI & R. BUFFA 《Histopathology》1996,28(6):513-519
We performed an immunohistochemical analysis to investigate the expression of p53 protein in a panel of 18 laryngeal squamous cell carcinomas, 15 primary tumours and three in relapse, previously analysed by us for the presence of p53 gene mutations. Dysplastic and/or normal surrounding mucosa was evaluated in 15 different tumours. The results of our study are the following: (1) expression of p53 protein was observed in one out of five tumours positive for p53 gene mutations (20%) and in 10 out of 13 (80%) negative cases; (2), p53 protein over-expression was frequently observed in normal and/or dysplastic mucosa surrounding either wild-type (7/11) or mutated p53 tumours (2/4); (3), p53 immunoreactive cells showed a pattern of distribution in normal and mildly/moderately dysplastic mucosa (basal layers), different from that in severely dysplastic mucosa (whole thickness). These data further support the hypothesis that p53 protein over-expression may be a marker of the earliest phases of multistep tumorigenesis in laryngeal squamous cell carcinoma. 相似文献
10.
毛喉萜对人肝癌细胞增殖影响的实验研究 总被引:1,自引:0,他引:1
目的 探讨毛喉萜 (Forskolin)的抗肝癌作用。方法 采用克隆形成、MTT比色法观察毛喉萜对SMMC 772 1细胞的作用 ,并利用免疫细胞化学方法检测其对rasp2 1、p5 3蛋白表达的影响。结果 毛喉萜可明显抑制SMMC 772 1细胞的增殖 ,其抑制率与剂量呈正相关 (P <0 .0 1 ) ,经毛喉萜处理后 ,rasp2 1、p5 3蛋白表达均有明显下降。结论 毛喉萜能明显抑制肝癌SMMC 772 1细胞增殖 ,其作用可能与降低rasp2 1、p5 3蛋白表达有关。 相似文献